Results 191 to 200 of about 18,985 (204)

Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials

European Journal of Cancer, 2012
Alison Stopeck, Salvatore Siena, Philippe Beuzeboc   +2 more
exaly  

Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan

Osteoporosis International, 2017
Kumiko Moriwaki, Hiroshi Hagino
exaly  

The efficacy of zoledronic acid in breast cancer adjuvant therapy: A meta-analysis of randomised controlled trials

European Journal of Cancer, 2012
Tingting Yan, Wenjin Yin, Liheng Zhou
exaly  

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

Lancet, The, 2011
Michael Carducci, Ronaldo Damiao, Janet E Brown   +2 more
exaly  

Zoledronic acid inhibits primary bone tumor growth in Ewing sarcoma

Cancer, 2005
Xiaoping Duan, Eugenie S Kleinerman
exaly  

A multicenter, randomized clinical trial comparing zoledronic acid versus observation in patients with asymptomatic myeloma

Cancer, 2008
Pellegrino Musto, Tommasina Guglielmelli, Alessandro Andriani   +2 more
exaly  

A prospective, randomized, placebo-controlled trial of zoledronic acid in bony metastatic bladder cancer

International Journal of Clinical Oncology, 2010
Mohamed S Zaghloul, Zaghloul Mohamed S
exaly  

Zoledronic acid

Reactions Weekly, 2009
openaire   +1 more source

Sequence‐ and schedule‐dependent enhancement of zoledronic acid induced apoptosis by doxorubicin in breast and prostate cancer cells

International Journal of Cancer, 2005
Amin Rostami-Hodjegan, Ingunn Holen
exaly  

STAT pathway in the regulation of zoledronic acid-induced apoptosis in chronic myeloid leukemia cells

Biomedicine and Pharmacotherapy, 2013
Burcin Tezcanlı Kaymaz, Nur Selvi, Cigir Biray Avci   +2 more
exaly